Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Eton Pharmaceuticals, Inc. (ETON) had Stock-Based Compensation of $3.30M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$18.93M |
|
$-2.58M |
|
$7.00M |
|
$11.92M |
|
$20.40M |
|
$-1.48M |
|
$-1.04M |
|
$-2.52M |
|
$-2.52M |
|
$-2.58M |
|
$-2.58M |
|
$-2.58M |
|
$-2.58M |
|
$-1.48M |
|
$-0.42M |
|
26.89M |
|
26.89M |
|
$-0.10 |
|
$-0.10 |
|
| Balance Sheet Financials | |
$68.44M |
|
$0.02M |
|
$33.23M |
|
$101.68M |
|
$38.60M |
|
$27.41M |
|
$39.12M |
|
$77.72M |
|
$23.96M |
|
$-8.92M |
|
$23.96M |
|
26.82M |
|
| Cash Flow Statement Financials | |
$10.05M |
|
-- |
|
$0.39M |
|
$14.94M |
|
$25.38M |
|
$10.44M |
|
|
Stock-Based Compensation |
$3.30M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.77 |
|
-- |
|
-- |
|
0.53 |
|
1.26 |
|
63.00% |
|
-7.79% |
|
-7.79% |
|
-- |
|
-13.31% |
|
-13.66% |
|
$10.05M |
|
-- |
|
-- |
|
-- |
|
0.19 |
|
0.29 |
|
1.31 |
|
68.72 |
|
-10.79% |
|
28.99% |
|
-2.54% |
|
-5.03% |
|
$0.89 |
|
$0.37 |
|
$0.37 |
|